GI Oncology
Feature
Maintaining cancer care in the face of COVID-19
Oncologists are moving cancer patients to other hospitals, reevaluating the need for cancer treatments, and embracing telemedicine to protect...
From the Journals
Blood test might detect multiple cancer types, study suggests
The test, which uses methylation patterns in plasma cell-free DNA, had specificity and sensitivity approaching those needed for population-based...
From the Journals
Liver cancer risk reduced by aspirin in chronic viral hepatitis
Patients taking low-dose aspirin had a 31% lower risk of hepatocellular carcinoma.
News from the FDA/CDC
Age divide seen in colorectal cancer screening use
Americans aged 65-75 years are significantly more likely than 50- to 64-year-olds to be up to date with colorectal cancer screening.
From the Journals
Study eyes gastric cancer predictors in Lynch syndrome
Risk factors included older age, male sex, family history, and having pathogenic variants in MLH1 or MSH2.
From the Journals
Bariatric surgery may curtail colorectal cancer risk
From the Journals
Molecularly guided therapy in pancreatic cancer: Untapped potential and the ‘bright future’ ahead
Molecularly guided therapy improved overall survival in a retrospective study, but this treatment approach was underused.
From the Journals
Colorectal cancer burden rises in younger age groups
From the Journals
Preoperative chemoradiotherapy failed to boost overall survival in pancreatic cancer
Preoperative chemoradiotherapy did not improve overall survival but did improve disease-free survival and other endpoints.
From the Journals
Review reveals shorter OS, RFS in young colorectal cancer patients
Peritoneal metastasis occurred significantly more often in younger patients, but predisposing conditions such as polyposis or congenital colon...
From the Journals
E. coli strain directly linked with CRC mutational signature
Recent studies showed that colibactin, a toxin produced by pks+ E. coli, causes a specific type of DNA damage.